Skip to main content
Erschienen in: Herz 1/2011

01.02.2011 | Original article

Renoprotective effect of small volumes of hypertonic saline solution in chronic heart failure patients with marked fluid retention: results of a case-control study

verfasst von: Dr. R. De Vecchis, M.D., A. Ciccarelli, C. Ariano, A. Pucciarelli, C. Cioppa, A. Giasi, A. Fusco, S. Cantatrione

Erschienen in: Herz | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

During intensive therapy of chronic heart failure (CHF) patients with marked fluid retention using high doses of i.v. furosemide the additional effect of agents which might exert osmotic attraction of interstitial fluids has been proposed. They are thought to impede the impairment of renal blood supply and glomerular filtration rate, which may be caused by a combined action of cardiac preload acute reduction, hypotension and neurohormonal activation.
We therefore assessed in CHF patients with NYHA class III and BNP values from 900 to 1500 pg/ml, who were treated with i.v. furosemide, the predictors of iatrogenic short term creatinine impairment by means of a case-control observational study from two centers. Patients with CHF had been treated for 6–8 days with intravenous loop diuretics alone or with an additional i.v. administration of other agents (plasma expanders, albumin, mannitol, inotropic support etc.). A rise in serum creatinine ≥25% of the basal value was considered as renal impairment.
A total of 15 cases and 38 controls were enrolled. At univariate analysis, serum creatinine basal value ≥2.2 mg/dl, absence of hypertonic saline solution (HSS) in the therapeutic protocol, hyposodic diet and refractory oligoanuria were associated with an increased risk of worsening renal function precipitated by i.v. diuretic therapy. At multivariate analysis as a predictor of loop diuretic-related renal function impairment, we found a serum creatinine ≥2.2 mg/dl at baseline (OR: 63.33, 95% CI: 3.68–1088.73, p=0.0043) and the absence of HSS in the therapeutic regimen (OR: 25.0461, 95% CI: 2.07–302.53, p=0.0113). Moreover, in multivariate analysis ascites had some predictive value of renal deterioration (OR: 13.28, 95% CI: 1.0055–175.41, p=0,0495).
Literatur
1.
Zurück zum Zitat Cody RJ (1998) Diuretics in the management of congestive heart failure. Cardiologia 43:25–34PubMed Cody RJ (1998) Diuretics in the management of congestive heart failure. Cardiologia 43:25–34PubMed
2.
Zurück zum Zitat Brater DC (1994) Diuretic resistance: mechanisms and therapeutic strategies. Cardiology 84:57–67CrossRefPubMed Brater DC (1994) Diuretic resistance: mechanisms and therapeutic strategies. Cardiology 84:57–67CrossRefPubMed
3.
Zurück zum Zitat Dormans TPJ, Van Meyel JJM, Gerlag PGG et al (1996) Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 28:376–382CrossRefPubMed Dormans TPJ, Van Meyel JJM, Gerlag PGG et al (1996) Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 28:376–382CrossRefPubMed
4.
Zurück zum Zitat Smith THW, Kelly RA, Stevenson LW, Braunwald E (1997) Management of heart failure. In: Braunwald E (ed) Heart disease: a textbook of cardiovascular medicine. WB Saunders, Pennsylvania, Philadelphia, pp 492–514 Smith THW, Kelly RA, Stevenson LW, Braunwald E (1997) Management of heart failure. In: Braunwald E (ed) Heart disease: a textbook of cardiovascular medicine. WB Saunders, Pennsylvania, Philadelphia, pp 492–514
5.
Zurück zum Zitat Christ M, Ludwig N, Maisch B (2002) Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure. Herz 27(2):135–149CrossRefPubMed Christ M, Ludwig N, Maisch B (2002) Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure. Herz 27(2):135–149CrossRefPubMed
6.
Zurück zum Zitat Grimm W (2006) What is evidence-based, what is new in medical therapy of acute heart failure? Herz 31(8):771–779CrossRefPubMed Grimm W (2006) What is evidence-based, what is new in medical therapy of acute heart failure? Herz 31(8):771–779CrossRefPubMed
7.
Zurück zum Zitat Maisch B, Pankuweit S (2010) Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery. Herz 35(2):94–101CrossRefPubMed Maisch B, Pankuweit S (2010) Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery. Herz 35(2):94–101CrossRefPubMed
8.
Zurück zum Zitat Schrier RW (1990) Effects of furosemide treatment in patients with congestive heart failure. In: Lasix 25th Anniversary Symposium. Proceedings of the International Symposium, page 83–94, Frankfurt am Main 1989. Media Medica, Frankfurt am Main Schrier RW (1990) Effects of furosemide treatment in patients with congestive heart failure. In: Lasix 25th Anniversary Symposium. Proceedings of the International Symposium, page 83–94, Frankfurt am Main 1989. Media Medica, Frankfurt am Main
9.
Zurück zum Zitat Brandimarte F, Mureddu GF, Boccanelli A et al (2010) Diuretic therapy in heart failure: current controversies and new approaches for fluid removal. J Cardiovasc Med (Hagerstown) 11(8):563–570CrossRef Brandimarte F, Mureddu GF, Boccanelli A et al (2010) Diuretic therapy in heart failure: current controversies and new approaches for fluid removal. J Cardiovasc Med (Hagerstown) 11(8):563–570CrossRef
10.
Zurück zum Zitat De Vecchis R, Ciccarelli A, Pucciarelli A (2010) Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon? J Cardiovasc Med (Hagerstown) 11(8):571–574 De Vecchis R, Ciccarelli A, Pucciarelli A (2010) Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon? J Cardiovasc Med (Hagerstown) 11(8):571–574
11.
Zurück zum Zitat MacFadyen RJ, Ng Kam Chuen MJ, Davis RC (2010) Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy? Eur J Heart Fail 12(7):649–652CrossRefPubMed MacFadyen RJ, Ng Kam Chuen MJ, Davis RC (2010) Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy? Eur J Heart Fail 12(7):649–652CrossRefPubMed
12.
Zurück zum Zitat Redfors B, Swärd K, Sellgren J, Ricksten SE (2009) Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med 35(1):115–122CrossRefPubMed Redfors B, Swärd K, Sellgren J, Ricksten SE (2009) Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med 35(1):115–122CrossRefPubMed
13.
Zurück zum Zitat Borgstroem P, Arfors KE, Intaglietta M (1988) Dynamic fluid redistribution in hyperosmotic resuscitation of hypovolemic hemorrhage. Am J Physiol 255:H629–H637 Borgstroem P, Arfors KE, Intaglietta M (1988) Dynamic fluid redistribution in hyperosmotic resuscitation of hypovolemic hemorrhage. Am J Physiol 255:H629–H637
14.
Zurück zum Zitat Maningas PA, Mattox KL, Pepe PE et al (1989) Hypertonic saline-dextran solutions for the prehospital management of traumatic hypotension. Am J Surg 157:528–534CrossRefPubMed Maningas PA, Mattox KL, Pepe PE et al (1989) Hypertonic saline-dextran solutions for the prehospital management of traumatic hypotension. Am J Surg 157:528–534CrossRefPubMed
15.
Zurück zum Zitat Armistead CW, Vincent JL, Preiser JC et al (1989) Hypertonic saline solution-hetastarch for fluid resuscitation in experimental septic shock. Anesth Analg 69:714–720CrossRefPubMed Armistead CW, Vincent JL, Preiser JC et al (1989) Hypertonic saline solution-hetastarch for fluid resuscitation in experimental septic shock. Anesth Analg 69:714–720CrossRefPubMed
16.
Zurück zum Zitat Paterna S, Di Pasquale P, Parrinello G et al (2000) Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur J Heart Fail 2(3):305–313CrossRefPubMed Paterna S, Di Pasquale P, Parrinello G et al (2000) Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur J Heart Fail 2(3):305–313CrossRefPubMed
17.
Zurück zum Zitat Licata G, Di Pasquale P, Parrinello G et al (2003) Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 145(3):459–466CrossRefPubMed Licata G, Di Pasquale P, Parrinello G et al (2003) Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 145(3):459–466CrossRefPubMed
18.
Zurück zum Zitat Paterna S, Di Pasquale P, Parrinello G et al (2005) Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 45(12):1997–2003CrossRefPubMed Paterna S, Di Pasquale P, Parrinello G et al (2005) Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 45(12):1997–2003CrossRefPubMed
19.
Zurück zum Zitat Paterna S, Fasullo S, Di Pasquale P (2005) High-dose torasemide is equivalent to high-dose furosemide with hypertonic saline in the treatment of refractory congestive heart failure. Clin Drug Investig 25(3):165–173CrossRefPubMed Paterna S, Fasullo S, Di Pasquale P (2005) High-dose torasemide is equivalent to high-dose furosemide with hypertonic saline in the treatment of refractory congestive heart failure. Clin Drug Investig 25(3):165–173CrossRefPubMed
20.
Zurück zum Zitat Cioffi G, Tarantini L, Pulignano G et al (2007) Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure. J Cardiovasc Med (Hagerstown) 8(6):419–427CrossRef Cioffi G, Tarantini L, Pulignano G et al (2007) Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure. J Cardiovasc Med (Hagerstown) 8(6):419–427CrossRef
21.
Zurück zum Zitat Pozzoli M, Capomolla S, Pinna G et al (1996) Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J Am Coll Cardiol 27:883–893CrossRefPubMed Pozzoli M, Capomolla S, Pinna G et al (1996) Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J Am Coll Cardiol 27:883–893CrossRefPubMed
22.
Zurück zum Zitat Temporelli PL, Scapellato F, Corra U et al (1999) Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation. Am J Cardiol 83:724–727CrossRefPubMed Temporelli PL, Scapellato F, Corra U et al (1999) Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation. Am J Cardiol 83:724–727CrossRefPubMed
23.
Zurück zum Zitat Capomolla S, Febo O, Caporotondi A et al (2000) Non-invasive estimation of right atrial pressure by combined Doppler echocardiographic measurements of the inferior vena cava in patients with congestive heart failure. Ital Heart J 1(10):684–690PubMed Capomolla S, Febo O, Caporotondi A et al (2000) Non-invasive estimation of right atrial pressure by combined Doppler echocardiographic measurements of the inferior vena cava in patients with congestive heart failure. Ital Heart J 1(10):684–690PubMed
24.
Zurück zum Zitat Gheorghiade M, Follath F, Ponikowski P et al (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12(5):423–433CrossRefPubMed Gheorghiade M, Follath F, Ponikowski P et al (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12(5):423–433CrossRefPubMed
25.
Zurück zum Zitat Ezekowitz JA, Hernandez AF, Starling RC et al (2009) Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). Am Heart J 157:219–228CrossRefPubMed Ezekowitz JA, Hernandez AF, Starling RC et al (2009) Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). Am Heart J 157:219–228CrossRefPubMed
26.
Zurück zum Zitat Gottlieb SS, Skettino SL, Wolff A et al (2000) Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 35(1):56–59CrossRefPubMed Gottlieb SS, Skettino SL, Wolff A et al (2000) Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 35(1):56–59CrossRefPubMed
27.
Zurück zum Zitat Guiotto G, Masarone M, Paladino F et al (2010) Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot study. Intensive Care Med 36(4):692–696CrossRefPubMed Guiotto G, Masarone M, Paladino F et al (2010) Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot study. Intensive Care Med 36(4):692–696CrossRefPubMed
28.
Zurück zum Zitat Mullens W, Abrahams Z, Skouri HN et al (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51(3):300–306CrossRefPubMed Mullens W, Abrahams Z, Skouri HN et al (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51(3):300–306CrossRefPubMed
29.
Zurück zum Zitat Mullens W, Abrahams Z, Francis GS et al (2008) Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 14(6):508–514CrossRefPubMed Mullens W, Abrahams Z, Francis GS et al (2008) Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 14(6):508–514CrossRefPubMed
30.
Metadaten
Titel
Renoprotective effect of small volumes of hypertonic saline solution in chronic heart failure patients with marked fluid retention: results of a case-control study
verfasst von
Dr. R. De Vecchis, M.D.
A. Ciccarelli
C. Ariano
A. Pucciarelli
C. Cioppa
A. Giasi
A. Fusco
S. Cantatrione
Publikationsdatum
01.02.2011
Verlag
Urban and Vogel
Erschienen in
Herz / Ausgabe 1/2011
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-010-3394-3

Weitere Artikel der Ausgabe 1/2011

Herz 1/2011 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.